DK440577A - Fremgangsmaade til idenfificering af overfladeproteiner paa cancerceller klinisk proevemetode til paavisning af immunitet og fremgangsmaade til immunisering - Google Patents

Fremgangsmaade til idenfificering af overfladeproteiner paa cancerceller klinisk proevemetode til paavisning af immunitet og fremgangsmaade til immunisering

Info

Publication number
DK440577A
DK440577A DK440577A DK440577A DK440577A DK 440577 A DK440577 A DK 440577A DK 440577 A DK440577 A DK 440577A DK 440577 A DK440577 A DK 440577A DK 440577 A DK440577 A DK 440577A
Authority
DK
Denmark
Prior art keywords
immunization
cancer cells
surface proteins
clinical test
identifying surface
Prior art date
Application number
DK440577A
Other languages
English (en)
Inventor
R H Reid
Original Assignee
R H Reid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R H Reid filed Critical R H Reid
Publication of DK440577A publication Critical patent/DK440577A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK440577A 1976-10-08 1977-10-05 Fremgangsmaade til idenfificering af overfladeproteiner paa cancerceller klinisk proevemetode til paavisning af immunitet og fremgangsmaade til immunisering DK440577A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/730,764 US4174385A (en) 1976-10-08 1976-10-08 Method of identification of surface proteins of cancer cells, clinical test and method of immunization

Publications (1)

Publication Number Publication Date
DK440577A true DK440577A (da) 1978-04-09

Family

ID=24936725

Family Applications (1)

Application Number Title Priority Date Filing Date
DK440577A DK440577A (da) 1976-10-08 1977-10-05 Fremgangsmaade til idenfificering af overfladeproteiner paa cancerceller klinisk proevemetode til paavisning af immunitet og fremgangsmaade til immunisering

Country Status (8)

Country Link
US (1) US4174385A (da)
JP (1) JPS5386016A (da)
AU (1) AU2949677A (da)
DE (1) DE2745237A1 (da)
DK (1) DK440577A (da)
FR (1) FR2372172A1 (da)
NL (1) NL7710995A (da)
SE (1) SE7710957L (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1165552B (it) * 1979-01-30 1987-04-22 Otsuka Pharma Co Ltd Procedimento e corredo per determinare il livello di glicolegami associati a tumore
JPS55136235A (en) * 1979-04-09 1980-10-23 Teijin Ltd Antitumor protein complex and its preparation
SE447263B (sv) * 1979-04-20 1986-11-03 Bonnierfoeretagen Ab Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid
JPS5616418A (en) * 1979-07-20 1981-02-17 Teijin Ltd Antitumor protein complex and its preparation
USRE32417E (en) * 1979-10-29 1987-05-12 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
US4361544A (en) * 1980-03-03 1982-11-30 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4444744A (en) * 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens
EP0035265B1 (en) * 1980-03-03 1986-01-02 Milton David Goldenberg Agent for tumor localization and therapy with labeled antibodies and antibody fragments
US4348376A (en) * 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody
US4460561A (en) * 1980-03-03 1984-07-17 Goldenberg M David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
EP0057236A4 (en) * 1980-07-25 1982-10-14 Otsuka Pharma Co Ltd METHOD FOR DETERMINING A SIDE CHAIN OF GLUCOSE ASSOCIATED WITH A TUMOR, METHOD FOR DIAGNOSING TUMORS, AND "KIT" FOR DIAGNOSING TUMORS.
NO830570L (no) * 1982-02-22 1983-08-23 Carlton Med Prod Antistoffer og antigener for diagnose og behandling av cancer
IE820942L (en) * 1982-04-21 1983-10-21 Bartos Patent Dev Holding Determining in-viro effectiveness of cytostatic agents
US4542750A (en) * 1982-08-13 1985-09-24 Primary Diagnostic Systems, Inc. Non-invasive method for diagnosing incipient or developed cancer tissue
JPS59214766A (ja) * 1983-05-23 1984-12-04 Eisai Co Ltd 体液中にあるレクチン親和性物質検出用試薬
US5380774A (en) * 1989-11-28 1995-01-10 Hoechst Celanese Corporation Nylon molding compositions exhibiting improved protection against UV-light degradation
US5376531A (en) * 1992-09-03 1994-12-27 Northwestern University Method of detecting cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041023A (en) * 1976-04-14 1977-08-09 Hoffmann-La Roche Inc. Labelled peptides

Also Published As

Publication number Publication date
SE7710957L (sv) 1978-04-09
JPS5386016A (en) 1978-07-29
NL7710995A (nl) 1978-04-11
AU2949677A (en) 1979-04-26
DE2745237A1 (de) 1978-04-13
FR2372172A1 (fr) 1978-06-23
US4174385A (en) 1979-11-13

Similar Documents

Publication Publication Date Title
DK440577A (da) Fremgangsmaade til idenfificering af overfladeproteiner paa cancerceller klinisk proevemetode til paavisning af immunitet og fremgangsmaade til immunisering
DK156524C (da) Proevemiddel til paavisning af tilstedevaerelsen af en komponent i en analyseproeve samt fremgangsmaade og proevemiddelkomposition til fremstilling af samme
DK159407C (da) Fremgangsmaade og indretning til bestemmelse af antigeners eller antistoffers tilstedevaerelse
SE440280B (sv) Testforfarande och reagens med koenzymmerkning
DK157108C (da) Fremgangsmaade og apparat til detektering af fejl
DK135965B (da) Fremgangsmåde og prøvepakke til påvisning og bestemmelse af haptener.
DK137681A (da) Fremgangsmaade og anordning til bestemmelse af en asynkronmotors temperatur
IT1085755B (it) Apparecchiatura e metodo per la misura di pressioni e la indicazione di perdite mediante analisi ottiche
DK235887A (da) Immunoassaymetode og proevesaet til paavisning af et med human carcinoma forbundet antigen
DK285081A (da) Fremgangsmaade og apparat til detektering af fejl
DK138256B (da) Fremgangsmaade til udvinging af et overfor blodkoagulationsfaktorerne v!! og x foelsomt thrombinfrit thromboplastin
ES490788A0 (es) Un metodo de determinacion de la presencia de un enzima en un analizado
DK78980A (da) Proevningsmiddel til bestemmelse af glucose i en vaeskeformig proeve samt fremgangsmaade til fremstilling af proevemidlet
DK34278A (da) Fremgangsmaade og apparat til optisk paavisning af fejl i transparente genstande
DK553281A (da) Fremgangsmaade til paavisning af antistof
DK51481A (da) Fremgangsmaade til bestemmelse af carcinoembryonisk antigen
DK194576A (da) Fremgangsmade til pavisning af thrombose og prethrombose
DK311483A (da) Fremgangsmaade til paavisning af tilstedevaerelsen af et antigen eller antistof i en proevevaeske og proevesaet til udfoerelse af fremgangsmaaden
DK144395C (da) Fremgangsmaade og proevningssaet til proevning for tilstedevaerelsen af hepatitis b overfladeantigen i menneskeblod
DK16976A (da) Reagens og fremgangsmade til immunologiske undersogelser
DK166234C (da) Agglutineringstest til paavisning af antigener
DK151657C (da) Fremgangsmaade og apparat til udlaesning og/eller indskrivning af information
DK164143C (da) Fremgangsmaade og apparat til ikke-destruktiv afproevning af daek
DK421977A (da) Immunologisk paavisningsmetode
IT1090319B (it) Metodo ed apparato di prova di lenti